Antibiotic-eluting hydrophilized PMMA bone cement with prolonged bactericidal effect for the treatment of osteomyelitis

作者：Oh Eun Jo; Oh Se Heang; Lee In Soo; Kwon Oh Soo; Lee Jin Ho^*

来源：Journal of Biomaterials Applications, 2016, 30(10): 1534-1544.

DOI：10.1177/0885328216629823

• Osteomyelitis
• PMMA bone cement
• antibiotic
• amphiphilic additive
• local delivery

Osteomyelitis is still considered to be one of the major challenges for orthopedic surgeons despite advanced antiseptic surgical procedures and pharmaceutical therapeutics. In this study, hydrophilized poly(methyl methacrylate) (PMMA) bone cements containing Pluronic F68 (EG(79)PG(28)EG(79)) as a hydrophilic additive and vancomycin (F68-VA cements) were prepared to allow the sustained release of the antibiotic for adequate periods of time without any significant loss of mechanical properties. The compressive strengths of the bone cements with Pluronic F68 compositions less than 7wt% were not significantly different compared with the control vancomycin-loaded bone cement (VA cement). The F68 (7wt%)-VA cement showed sustained release of the antibiotic for up to 11 weeks and almost 100% release from the bone cement. It also prohibited the growth of S. aureus (zone of inhibition) over six weeks (the required period to treat osteomyelitis), and it did not show any notable cytotoxicity. From an animal study using a femoral osteomyelitis rat model, it was observed that the F68 (7wt%)-VA cement was effective for the treatment of osteomyelitis, probably as a result of the prolonged release of antibiotic from the PMMA bone cement. On the basis of these findings, it can be suggested that the use of Pluronic F68 as a hydrophilic additive for antibiotic-eluting PMMA bone cement can be a promising strategy for the treatment of osteomyelitis.

• 出版日期2016-5